Title:
フラビウイルス融合インヒビター
Document Type and Number:
Japanese Patent JP5250179
Kind Code:
B2
Abstract:
The present invention relates to peptides and use of said peptides in methods of inhibiting fusion between the virion envelope of Flaviviruses and membranes of the target cell, the process that delivers the viral genome into the cell cytoplasm. The invention provides also for pharmaceutical compositions comprising said peptides or peptide derivatives. The invention also relates to antibodies specific for said peptides.
More Like This:
WO/2012/118559 | TETRAVALENT AND MIXED HEAD BIVALENT DENGUE VACCINE |
JPH02167081 | GENOME RNA OF HEPATITIS VIRUS OF NON-A, NON-B TYPE, CDNA AND VIRAL ANTIGEN PROTEIN |
WO/2018/005733 | FISH VIRUS |
Inventors:
Gary Robert F
Dash slicant
Koi David H
McKeeting Jane A
Dash slicant
Koi David H
McKeeting Jane A
Application Number:
JP2004551940A
Publication Date:
July 31, 2013
Filing Date:
November 07, 2003
Export Citation:
Assignee:
The Adminstrators of the Tulane Educational Fund
The Rockefeller University
The Rockefeller University
International Classes:
C07K14/18; A61K38/00; A61K38/16; A61K39/12; A61K39/193; A61K39/29; A61K39/295; A61K39/38; A61P31/14; C07K16/10; A61K39/00; A61P31/12; C12Q
Domestic Patent References:
JP62286930A | ||||
JP5148298A | ||||
JP9509052A |
Foreign References:
WO2002072835A1 | ||||
EP0982402A1 |
Other References:
K. D. Ryman,Journal of General Virology,1997年,Vol.78,Pages 1353-1356
GARCIA,J.E. et al,Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells,Journal of hepatology,2002年,Vol.36, No.2,p.254-62
GARCIA,J.E. et al,Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells,Journal of hepatology,2002年,Vol.36, No.2,p.254-62
Attorney, Agent or Firm:
Sadao Kumakura
Atsushi Hakoda
Kenji Asai
Atsushi Hakoda
Kenji Asai